Adverse events include mild hypoglycemia based on clinical studies.<unk>  is not associated with increased weight, increased risk of cardiovascular events. It may also cause joint pain that can be severe and disabling. In April 2016, the U.S. Food and Drug Administration (FDA) added a warning about increased risk of heart failure.
Alogliptin
Vildagliptin
Linagliptin
Sitagliptin
Saxagliptin
Liraglutide
Teneligliptin
Pioglitazone